Emily Fang, based in Cambridge, MA, US, is currently a Co-Founder CEO, Executive Board Member at InFocus Therapeutics, bringing experience from previous roles at InFocus Therapeutics, Oncodesign Services, Oncodesign and Charles River Laboratories. Emily Fang holds a The University of Dundee. With a robust skill set that includes Business Development, Biotechnology, Pharmaceutical Industry, Biopharmaceuticals, Drug Discovery and more, Emily Fang contributes valuable insights to the industry. Emily Fang has 2 emails on RocketReach.